German Spondyloarthritis Inception Cohort
|Conditions||ankylosing spondylitis, non-radiographic axial spondyloarthritis|
|Sponsor||Charite University, Berlin, Germany|
|Collaborator||German Federal Ministry of Education and Research (BMBF): 2000-2007 and 2010-current|
|Start date||July 2000|
|End date||July 2020|
|Trial size||1000 participants|
|Trial identifier||NCT01277419, GESPIC|
The German Spondyloarthritis Inception cohort (GESPIC) was started as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of AS and other SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs).
Recruiting in the following locations…
|United States||No locations recruiting|
All participants of any age.
Main inclusion Criteria: - AS fulfilling the modified New York criteria, and the duration of AS symptoms (usually back pain) ≤10 years at the time of inclusion. - Patients with Crohn's disease and symptom duration ≤5 years at the time of inclusion.
|Official title||German Spondyloarthritis Inception Cohort|
|Principal investigator||Denis Poddubnyy, Prof. Dr.|
Call for more information